Prospective observational studies for cancer therapies.

Leverage RDW using xCures’ oncology platform.

Through partnerships with advocacy organizations, physicians, and research networks, patients enroll directly on our HIPAA-compliant platform.

The platform accepts records from any US-based institution in any form. It compiles the data into a pan-cancer registry under an IRB-approved master protocol suitable for FDA submissions and medical publications.

Cancer patients pay with their data. They continuously engage with the xCures platform giving researchers rich, longitudinal real-world data for oncology studies and programs.